跳至主要内容
临床试验/NCT05465304
NCT05465304已完成不适用

Effect of Azithromycin on Pregnancy Prolongation in Women at Risk for Premature Labour

Beni-Suef University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
Effect of Azithromycin in preventing premature labour

研究概览

简要总结

This is a prospective observational case controlled study. The control group will include pregnant women, having intact membranes and are at risk of or in preterm labour, administrating the standard treatments for prolongation of pregnancy.

The test group will involve pregnant women, having intact membranes and are at risk of or in preterm labour, administrating the standard treatments for prolongation of pregnancy plus azithromycin

详细描述

A prospective randomized clinical study was conducted in the outpatient clinic of the gynecology department of Beni Suef University Hospital, Beni-Suef, Egypt, between October 01, 2021, and April 30, 2022. The study included 211 pregnant women aged between 20 to 41 years. These patients were randomized into three groups.

The first group which was the control group, included pregnant women, having intact membranes and are at risk of or in preterm labour, administrating the standard treatments (progesterone) for prolongation of pregnancy. While the second group which was the first test group, involved pregnant women, having intact membranes and are at risk of or in preterm labour, administrating the standard treatments for prolongation of pregnancy plus azithromycin for 5 days every month.

. The third group was the second test group in which the pregnant women administerated Azithromycin and clindamycin (Dalacin®) vaginal gel 5 times per month.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 32 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women with <34 weeks of gestation,
  • Hospitalization for risk of preterm labour,
  • Threat of preterm labour, or preterm labour itself.
  • Threat of preterm labour and preterm labour will have to be diagnosis cited in the medical record by the physician.
  • Women at risk of preterm labour must have one of the following conditions cited in their record: sludge, short cervix, cerclage, or bulging membranes

排除标准

  • Patients were excluded from the current study in case of the use of antibiotics within 14 days before the admission (except for pericerclage prophylaxis, or streptococcus B prophylaxis), PPROM or fetal extraction required <37 weeks.

研究组 & 干预措施

Azithromycin group

the first test group, involved pregnant women, having intact membranes and are at risk of or in preterm labour, administrating the standard treatments for prolongation of pregnancy plus azithromycin for 5 days every month

干预措施: Azithromycin (Drug)

Azithromycin plus Clindamycin group

the second test group in which the pregnant women administerated Azithromycin and clindamycin (Dalacin®) vaginal gel 5 times per month.

干预措施: Azithromycin (Drug)

结局指标

主要结局

Effect of Azithromycin in preventing premature labour

时间窗: 6 monthes

Main outcome was the number of days between diagnosis and composite event, defined as delivery or rupture of membranes or 2nd intervention aimed at prolonging pregnancy (such as cerclage or tocolysis) or censure (maternal death or transfer). The three groups were compared regarding this number of days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Raghda R.S. Hussein

Assistant Professor of Clinical Pharmacy

Beni-Suef University

研究点 (1)

Loading locations...

相似试验